1-3 of 3
Joana Duran
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Phase 2 Study of Daratumumab (DARA) Plus Bortezomib, Cyclophosphamide, and Dexamethasone (D-VCd) in a Diverse Patient Population with Newly Diagnosed Amyloid Light Chain (AL) Amyloidosis: Aquarius

Michael Rosenzweig, Yvonne Efebera, Efstathios Kastritis, Brandon Blue, Faizi Jamal, Monique C Minnema, Christopher Pericone, Sandra Vasey, Yuping Chen, Sonja Kotoulek, Bart Vandael, Joana Duran, Samer Khaled, NamPhuong Tran, Jessica Vermeulen, Vaishali Sanchorawala
Journal: Blood
Blood (2023) 142 (Supplement 1): 4785.
https://doi.org/10.1182/blood-2023-181953
Published: 2023
Journal Articles

Impact of Disease Progression, Line of Therapy, and Response on Health-Related Quality of Life in Multiple Myeloma: A Systematic Literature Review

Rafael Fonseca, Diana Tran, Emily Rosta, Alyshia Laidlaw, Manvir Rai, Joana Duran, Eric M. Ammann
Journal: Blood
Blood (2022) 140 (Supplement 1): 5212–5213.
https://doi.org/10.1182/blood-2022-165569
Published: 2022
Journal Articles

Phase 2 Study of Daratumumab (DARA) Plus Bortezomib, Cyclophosphamide, and Dexamethasone (D-VCd) in Patients with Newly Diagnosed Amyloid Light Chain (AL) Amyloidosis: Aquarius

Vaishali Sanchorawala, Michael Rosenzweig, Christopher Pericone, Sandra Y. Vasey, Xiang Qin, Sonja Marie Kotoulek, Bart Vandael, Joana Duran, Samer Khaled, NamPhuong Tran, Efstathios Kastritis
Journal: Blood
Blood (2022) 140 (Supplement 1): 10163–10164.
https://doi.org/10.1182/blood-2022-163615
Published: 2022